VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
This Quarter Return
-34.99%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$100M
AUM Growth
+$100M
(-46%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
CRISPR Therapeutics
CRSP
$4.71B
| $31.3M | 31.24% | 498,558 | – | – |
|
2
Passage Bio
PASG
$22.7M
| $15.4M | 15.35% | 4,959,769 | – | – |
|
|
GRTS
3
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $14.7M | 14.65% | 3,561,150 | – | – |
|
4
Crinetics Pharmaceuticals
CRNX
$2.92B
| $9.01M | 8.99% | 410,360 | – | – |
|
5
Akero Therapeutics
AKRO
$3.74B
| $8.77M | 8.75% | 617,727 | – | – |
|
|
UTRS
6
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
| $7.53M | 7.52% | 1,673,700 | – | – |
|
7
Adverum Biotechnologies
ADVM
$64.6M
| $6.64M | 6.63% | 5,068,233 | – | – |
|
8
Aligos Therapeutics
ALGS
$73.3M
| $4.99M | 4.98% | 2,320,381 | – | – |
|
|
CBAY
9
DELISTED
Cymabay Therapeutics
CBAY
| $1.69M | 1.69% | 543,753 | – | – |
|
|
CLVS
10
DELISTED
Clovis Oncology, Inc.
CLVS
| $206K | 0.21% | 101,855 | – | – |
|